4
Aug 18 (Reuters) – Alphamab Oncology: * NMPA ACCEPTS NDA FOR ANBENITAMAB (KN026) WITH HB1801 FOR HER2+ ADVANCED BREAST CANCER Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
First published on: Aug 18, 2026 3:49 PM IST
——————————————–
————————————————–
Stay informed on all the latest news, breaking news updates, and check all the important headlines in India news, World News, Sports News and Entertainment News on NewsX. Follow Us on Facebook, Twitter.
You Might Be Interested In
